Potential role of PET/MRI in radiotherapy treatment planning

State-of-the art radiotherapy (RT) techniques have become extremely flexible. As a consequence, highly conformal target doses in combination with optimal organ-at-risk sparing are possible. Due to this highly precise application of complex dose distributions, treatments with higher radiation doses in the tumor but without increased toxicity levels are now feasible. This offers the possibility to adapt dose distributions according to individual radiation sensitivities as measured with functional imaging modalities. Recently, combined PET/MRI has become available. This novel hybrid imaging modality offers the possibility to simultaneously image anatomical, functional and molecular characteristics of a tumor. Consequently, PET/MRI may be an optimal basis for RT individualization. This review discusses different potential applications of PET/MRI for RT treatment planning, as well as technical challenges for the integration of multi-parametric PET/MRI data into RT treatment planning.

[1]  G. Brix,et al.  Imaging of hypoxia using PET and MRI. , 2012, Current pharmaceutical biotechnology.

[2]  G. Delso,et al.  PET–MR imaging using a tri-modality PET/CT–MR system with a dedicated shuttle in clinical routine , 2013, Magnetic Resonance Materials in Physics, Biology and Medicine.

[3]  Karl Otto,et al.  Volumetric modulated arc therapy: IMRT in a single gantry arc. , 2007, Medical physics.

[4]  C. Belka,et al.  [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning , 2009, Radiation oncology.

[5]  P. Lambin,et al.  Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation. , 2012, Lung cancer.

[6]  M. Schwaiger,et al.  Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. , 2008, International journal of radiation oncology, biology, physics.

[7]  Quynh-Thu Le,et al.  Validation that metabolic tumor volume predicts outcome in head-and-neck cancer. , 2012, International journal of radiation oncology, biology, physics.

[8]  U Oelfke,et al.  Optimization of Physical Dose Distributions with Hadron Beams: Comparing Photon IMRT with IMPT , 2003, Technology in cancer research & treatment.

[9]  Bernhard Schölkopf,et al.  MRI-Based Attenuation Correction for PET/MRI: A Novel Approach Combining Pattern Recognition and Atlas Registration , 2008, Journal of Nuclear Medicine.

[10]  Ursula Nestle,et al.  Biological imaging in radiation therapy: role of positron emission tomography , 2009, Physics in medicine and biology.

[11]  Matthias Hofmann,et al.  Hybrid PET/MRI of Intracranial Masses: Initial Experiences and Comparison to PET/CT , 2010, The Journal of Nuclear Medicine.

[12]  Daniela Thorwarth,et al.  Hypoxia dose painting by numbers: a planning study. , 2007, International journal of radiation oncology, biology, physics.

[13]  B. Schölkopf,et al.  Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  A. Sauter,et al.  Combined PET/MR Imaging — Technology and Applications , 2010, Technology in cancer research & treatment.

[15]  Ilja Bezrukov,et al.  MRI-Based Attenuation Correction for Whole-Body PET/MRI: Quantitative Evaluation of Segmentation- and Atlas-Based Methods , 2011, The Journal of Nuclear Medicine.

[16]  P. Lambin,et al.  Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  Daniela Thorwarth,et al.  Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer , 2005, BMC Cancer.

[18]  Daniela Thorwarth,et al.  Modelling and simulation of [18F]fluoromisonidazole dynamics based on histology-derived microvessel maps , 2011, Physics in medicine and biology.

[19]  W. Oyen,et al.  FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  R. Fisher,et al.  Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  C. Kuhl,et al.  MRI-Based Attenuation Correction for Hybrid PET/MRI Systems: A 4-Class Tissue Segmentation Technique Using a Combined Ultrashort-Echo-Time/Dixon MRI Sequence , 2012, The Journal of Nuclear Medicine.

[22]  Hyunjin Park,et al.  Detection of Aggressive Primary Prostate Cancer with 11C-Choline PET/CT Using Multimodality Fusion Techniques , 2009, Journal of Nuclear Medicine.

[23]  H H Quick,et al.  The effect of MR surface coils on PET quantification in whole-body PET/MR: results from a pseudo-PET/MR phantom study. , 2011, Medical physics.

[24]  Søren M Bentzen,et al.  Theragnostic imaging for radiation oncology: dose-painting by numbers. , 2005, The Lancet. Oncology.

[25]  J. Lee,et al.  Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  Manish Kakar,et al.  Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study , 2011, Radiation oncology.

[27]  Wade P. Smith,et al.  Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  T. Beyer,et al.  Effect of MR contrast agents on quantitative accuracy of PET in combined whole-body PET/MR imaging , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  F. Mottaghy,et al.  Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules? , 2012, International journal of radiation oncology, biology, physics.

[30]  D. Hristov,et al.  Adapting radiotherapy to hypoxic tumours , 2006, Physics in medicine and biology.

[31]  T. Beyer,et al.  Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience. , 2011, International journal of radiation oncology, biology, physics.

[32]  Sotirios Bisdas,et al.  Simultaneous PET/MR imaging in a human brain PET/MR system in 50 patients--current state of image quality. , 2012, European journal of radiology.

[33]  A. Drzezga,et al.  First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses , 2012, The Journal of Nuclear Medicine.

[34]  Fréderic Duprez,et al.  Adaptive dose painting by numbers for head-and-neck cancer. , 2011, International journal of radiation oncology, biology, physics.

[35]  Karin Haustermans,et al.  Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial , 2011, Trials.

[36]  J. van den Hoff,et al.  Combined PET/MR systems: an overview and comparison of currently available options. , 2012, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[37]  C C Ling,et al.  Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.

[38]  Bernhard Schölkopf,et al.  The effect of patient positioning aids on PET quantification in PET/MR imaging , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[39]  P. Choyke,et al.  Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. , 2010, Radiology.

[40]  Sigrid Stroobants,et al.  Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRI , 2009, Journal of Nuclear Medicine.

[41]  Axel Martinez-Möller,et al.  Evaluation of the attenuation properties of MR equipment for its use in a whole-body PET/MR scanner , 2010, Physics in medicine and biology.

[42]  P. Choyke,et al.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.

[43]  Heinz-Peter Schlemmer,et al.  PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications , 2010, Journal of Nuclear Medicine.

[44]  C. Claussen,et al.  Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study. , 2012, Radiology.

[45]  N. Schwenzer,et al.  MR/PET: a new challenge in hybrid imaging. , 2012, AJR. American journal of roentgenology.

[46]  Thomas Beyer,et al.  X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. , 2003, Seminars in nuclear medicine.

[47]  Jason A Koutcher,et al.  Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases. , 2010, International journal of radiation oncology, biology, physics.

[48]  Ciprian Catana,et al.  Simultaneous PET-MRI: a new approach for functional and morphological imaging , 2008, Nature Medicine.

[49]  Martin Soukup,et al.  Comparison of fixed-beam IMRT, helical tomotherapy, and IMPT for selected cases. , 2008, Medical physics.

[50]  G. Delso,et al.  Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner , 2011, The Journal of Nuclear Medicine.

[51]  D. Townsend,et al.  Physical and clinical performance of the mCT time-of-flight PET/CT scanner , 2011, Physics in medicine and biology.

[52]  Philippe Lambin,et al.  Functional MRI for radiotherapy dose painting. , 2012, Magnetic resonance imaging.

[53]  M Alber,et al.  On biologically conformal boost dose optimization. , 2003, Physics in medicine and biology.

[54]  Jan-Jakob Sonke,et al.  Comparative study of respiratory motion correction techniques in cone-beam computed tomography. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[55]  Daniela Thorwarth,et al.  Implementation of hypoxia imaging into treatment planning and delivery. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[56]  Maaike R Moman,et al.  Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone. , 2012, International journal of radiation oncology, biology, physics.

[57]  G. Brix,et al.  Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[58]  Nassir Navab,et al.  Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT Data , 2009, Journal of Nuclear Medicine.